Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors. [electronic resource]
Producer: 20121011Description: 3284-6 p. digitalISSN:- 1464-3405
- Animals
- Biological Availability
- CCR5 Receptor Antagonists
- Cell Line
- Drug Design
- HIV Fusion Inhibitors -- chemical synthesis
- HIV-1 -- drug effects
- Humans
- Inhibitory Concentration 50
- Microbial Sensitivity Tests
- Piperazines -- chemical synthesis
- Piperidines -- chemical synthesis
- Solubility
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.